Verrica Pharmaceuticals Stock Momentum Indicators 1 day Rate Of Change of a Triple Smooth EMA

VRCA Stock  USD 1.24  0.13  11.71%   
Verrica Pharmaceuticals momentum indicators tool provides the execution environment for running the 1 day Rate Of Change of a Triple Smooth EMA indicator and other technical functions against Verrica Pharmaceuticals. Verrica Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the 1 day Rate Of Change of a Triple Smooth EMA indicator function is designed to identify and follow existing trends. Momentum indicators of Verrica Pharmaceuticals are pattern recognition functions that provide distinct formation on Verrica Pharmaceuticals potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The 1-day Rate-Of-Change (ROC) of a Triple Smooth EMA is an alternative momentum indicator that shows Verrica Pharmaceuticals trend by ignoring insignificant cycles.

Verrica Pharmaceuticals Technical Analysis Modules

Most technical analysis of Verrica Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Verrica from various momentum indicators to cycle indicators. When you analyze Verrica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Verrica Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Verrica Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Verrica Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Verrica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Verrica Pharmaceuticals's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Verrica Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Verrica Pharmaceuticals, we also check how macroeconomic factors affect Verrica Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Graham Number3.814.61
Receivables Turnover1.161.1
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verrica Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.2110.91
Details
Intrinsic
Valuation
LowRealHigh
0.204.0613.76
Details
Naive
Forecast
LowNextHigh
0.031.7211.43
Details
6 Analysts
Consensus
LowTargetHigh
11.5312.6714.06
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Verrica Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verrica Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verrica Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verrica Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.84)
Revenue Per Share
0.198
Quarterly Revenue Growth
27.445
Return On Assets
(0.71)
Return On Equity
(20.60)
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.